SMITH & NEPHEW PLC
SN.
 Delayed - 08/16 11:35:20 am |
|
| 1060GBX | -0.42% |
Business Summary
| Healthcare | ||||
 | Healthcare Services | |||
| Healthcare Equipment & Supplies | |||
| Medical Equipment, Supplies & Distribution | |||
| Medical Devices & Implants | |||
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows:
- orthopedic surgery (42.1%): primarily orthopedic implants (hips, knees and shoulders) ;
- sports medicine, arthroscopy and cervicofacial surgery (29.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.7%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 51.3% of net sales.
Number of employees : 18 369 people.
- orthopedic surgery (42.1%): primarily orthopedic implants (hips, knees and shoulders) ;
- sports medicine, arthroscopy and cervicofacial surgery (29.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.7%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 51.3% of net sales.
Number of employees : 18 369 people.
Sales per Business
| 2020 | 2021 | ||||
| Orthopaedics | 1 494.91 | 42% | 1 567.65 | 41.4% | |
| Sports Medicine & Ear, Nose and Throat | 1 039.49 | 29.2% | 1 134.29 | 29.9% | |
| Advanced Wound Management | 1 021.56 | 28.7% | 1 087.76 | 28.7% | |
| GBP in Million | |||||
Sales per region
| 2020 | 2021 | ||||
| United States | 1 823.99 | 51.3% | 1 932.66 | 51% | |
| Established Markets | 1 001.28 | 28.2% | 1 053.59 | 27.8% | |
| Emerging Markets | 353.26 | 9.9% | 410.09 | 10.8% | |
| China | 247.98 | 7% | 255.94 | 6.8% | |
| United Kingdom | 129.45 | 3.6% | 137.42 | 3.6% | |
| GBP in Million | |||||
Managers
| Name | Title |
| Deepak S Nath | Chief Executive Officer & Director |
| Anne-Francoise Nesmes | Chief Financial Officer & Executive Director |
| Roberto Quarta | Chairman |
| Ian Melling | Senior Vice President-Group Finance |
| Paul Connolly | President-Global Operations |
| Alison Parkes | Chief Compliance Officer |
| Erik Engstrom | Independent Non-Executive Director |
| Robin Freestone | Senior Independent Non-Executive Director |
| Angela Susan Risley | Independent Non-Executive Director |
| Marc E. Owen | Independent Non-Executive Director |
| Shareholders |
| Name | Equities | % |
| Wellington Management Co. LLP | 42,665,590 | 4.89% |
| BlackRock Investment Management (UK) Ltd. | 33,659,468 | 3.86% |
| The Vanguard Group, Inc. | 29,082,000 | 3.33% |
| Thornburg Investment Management, Inc. | 28,282,441 | 3.24% |
| WCM Investment Management LLC | 27,168,133 | 3.11% |
| BlackRock Fund Advisors | 24,767,742 | 2.84% |
| Walter Scott & Partners Ltd. | 23,162,340 | 2.65% |
| Norges Bank Investment Management | 18,200,000 | 2.09% |
| Rathbone Investment Management Ltd. | 16,817,000 | 1.93% |
| Fidelity Management & Research Co. LLC | 16,342,957 | 1.87% |
Company contact information
Building 5 Croxley Park
WD18 8YE Watford, Hertfordshire
Phone : +44 20 7401 7646
Fax : +44 20 7960 2356
web site : http://www.smith-nephew.com
WD18 8YE Watford, Hertfordshire
Phone : +44 20 7401 7646
Fax : +44 20 7960 2356
web site : http://www.smith-nephew.com
Markets and indexes
| - Main Market |
| - FTSE 100 / FTSE 350, FTSE All-Share, STOXX Europe 600, Stoxx UK 50 |
Stock Exchange Codes
| - Bloomberg Code : | SN/:LN |
| - Reuters Code : | SN.L |
Sector Medical Devices & Implants
| 1st jan. | Capi. (M$) | ||
 | |||
| SMITH & NEPHEW PLC | -24.35% | 11 172 | |
| |||
| STRYKER CORPORATION | -16.02% | 84 959 | |
| SMITH & NEPHEW PLC | -17.70% | 11 172 | |
| INSPIRE MEDICAL SYSTEMS, INC. | -2.66% | 6 412 | |
| AXONICS, INC. | 31.68% | 3 622 | |
| GLAUKOS CORPORATION | 18.65% | 2 508 | |
| DOUBLE MEDICAL TECHNOLOGY INC. | -27.02% | 2 264 | |
| SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. | -40.10% | 1 600 | |
| YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD. | 13.18% | 1 380 | |
| ORTHOPEDIATRICS CORP. | -5.33% | 1 192 | |
| OSSTEM IMPLANT CO., LTD. | -21.86% | 1 171 | |
| MEDARTIS HOLDING AG | -33.10% | 1 092 | |
| AK MEDICAL HOLDINGS LIMITED | -1.82% | 922 | |
| CERUS CORPORATION | -24.67% | 908 | |
| VENUS MEDTECH (HANGZHOU) INC. | -51.35% | 837 | |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | -34.37% | 795 | |
| DENTIUM CO., LTD | 43.27% | 652 | |
| JAPAN LIFELINE CO., LTD. | -4.29% | 613 | |
| PEIJIA MEDICAL LIMITED | -54.66% | 507 | |
| L&C BIO CO., LTD | -23.09% | 490 | |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | -54.12% | 465 | |
Brand Portfolio
